Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
30 years on and still more to do to educate gay men about HIV prevention

Thirty years after the discovery of virus, new research from NAT (National AIDS Trust) reveals that gay men are in the dark about new HIV prevention tools, with knowledge among 16-24 year olds particularly low.

Published
23 April 2014
From
NAT press release
Singapore Doc: "I remember the very first patient to whom I prescribed PrEP"

Many of my patients find it difficult to broach the topic of PrEP. Most of them share with me that they are worried about being judged. I try to assuage this by making the discussion factual, objective, scientific and professional.

Published
22 April 2014
From
My PrEP Experience (blog)
Head Of Largest U.S. HIV/AIDS Health Care Organization Still Insists Truvada Is A “Party Drug”

The leader of the nation’s largest community HIV/AIDS health care organization stands by sharp words he had for a drug that has been approved for its potential to prevent the transmission of HIV — comments that some doctors and activists say are “irresponsible” and even led to a petition demanding his resignation.

Published
22 April 2014
From
Buzzfeed
Medi-Cal Drops Providing Condoms and HIV Testing As Conditions for Prescribing Truvada

California’s Medi-Cal program has made it easier for low-income people to get access to Truvada, a drug believed to reduce the risk of contracting HIV, by eliminating requirements that those people be provided with condoms and be tested monthly for HIV and that their doctors seek Medi-Cal’s permission before writing a prescription.

Published
22 April 2014
From
WEHO ville
Px Wire: Long-Acting Injectables

In this issue, we review the research on long-acting injectable antiretrovirals for treatment in HIV-positive people and PrEP in HIV-negative people. The pathways for developing these products have key similarities as well as differences—and as the same drugs advance for treatment and PrEP, it will be key to communicate these.

Published
17 April 2014
From
AVAC
Petition to Remove AHF's Michael Weinstein for "Party Drug" remark about PrEP

A former model for one of the AIDS Healthcare Foundation (AHF)'s campaigns has set up an online petition demanding the resignation of Michael Weinstein, Chief Executive of AHF, after he described Truvada pre-exposure prophylaxis as a "party drug".

Published
16 April 2014
From
Change.org
Op-Ed: The Danger in Calling PrEP a "Party Drug"

Michael Lucas calls on the president of the AIDS Healthcare Foundation to be removed from his job for remarks about Truvada

Published
15 April 2014
From
Out
Why Aren’t Gay Men On The Pill?

If we can get a critical mass of gay men on either Truvada PrEP or retrovirals, we could soon reach a tipping point in which this virus could be wiped out in a generation.

Published
10 April 2014
From
The Dish
PROUD UK PrEP study completes enrolment – first data give participants' background and risk factors

The pilot stage of the PROUD study – the UK's study of HIV pre-exposure prophylaxis (HIV-negative people taking HIV drugs to prevent HIV) in gay

Published
09 April 2014
By
Gus Cairns
Long-acting HIV drugs advanced to overcome adherence challenge

If it proves effective, long-acting antiretroviral therapy would set up a new paradigm of monthly or quarterly injectable therapy for some patients. Long-acting drug formulations could solve one of the thorniest problems in HIV management - adherence.

Published
08 April 2014
From
Nature Medicine
← First12345...34Next →

Filter by country